Oncopeptides AB (publ)
ONPPF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$83,334 | -$61,251 | -$73,243 |
| Dep. & Amort. | – | $0 | $0 | $0 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $0 | $0 | $0 |
| Change in WC | – | -$7,095 | -$66,547 | $77,768 |
| Other Non-Cash | – | $18,931 | -$2,686 | $4,249 |
| Operating Cash Flow | – | -$71,498 | -$130,484 | $8,775 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | $0 | $0 | $0 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | $496 | $0 | $0 |
| Investing Cash Flow | – | $496 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | $0 | $0 |
| Stock Issued | – | $0 | $0 | $0 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | -$2,060 | -$1,956 | $269,837 |
| Financing Cash Flow | – | -$2,060 | -$1,956 | $269,837 |
| Forex Effect | – | $1,585 | -$823 | -$160 |
| Net Chg. in Cash | – | -$71,477 | -$133,264 | $278,450 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $250,013 | $383,277 | $104,825 |
| End Cash | – | $178,536 | $250,013 | $383,275 |
| Free Cash Flow | – | -$71,498 | -$130,484 | $8,775 |